Baxter AG, part of Baxter International, Inc., is a company headquartered in Volketswell, Switzerland. The firm wholesales pharmaceutical products.

Biotest Pharma GmbH engages in the manufacture and distribution of medicinal and pharmaceutical products. The company is headquartered in Dreieich, Germany.

Charles River Laboratories Cell Solutions, Inc. engages in the provision of bioresearch products and services for customer's research and cell therapy protocols. It offers human derived primary blood cells and tissues for biomedical research, supported cell therapy clinical trials and commercialization with apheresis collections, and provides a range of consulting services in standard operating procedure development, personnel training, and quality and regulatory compliance. The company was founded in 1978 and is headquartered in Northridge, CA.

Miles is a mobile app that automatically tracks and logs mileage for business purposes. Miles users can now create and export their mileage logs without the need of manual input.

Baxalta GmbH, a subsidiary of Takeda Pharmaceutical Co., Ltd., is a Swiss company located in Glattpark that manufactures and wholesales pharmaceutical products. It was founded in 2000. Julie So-Young Kim is currently the CEO of the firm.

Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL.

Green Cross Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.

Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

Takara Shuzo Co. Ltd. manufactures and markets alcoholic beverages. Its products include alcoholic beverages, raw alcohol, health drinks, and seasonings. The company was founded in 1925 and is headquartered in Kyoto, Japan.

Newsouth Innovations Pty Ltd., part of The University of New South Wales, is a company headquartered in Sydney, Australia, that provides support services for university of new south wales inventors turn their discoveries into innovations. The firm was founded in 1959. Kevin Cullen is the current CEO, occupying that position since 2011.

Chong Qing Kang Jia Guang Dian Ke Ji You Xian Gong Si, established on 2019-09-30, Business scope includes general items:design,research and development,Production,Sales:semiconductor,Optoelectronic devices,module,Display the product and its related products;Engineering and Technology Research and Experimental Development,Enterprise Management Services;semiconductor,Optoelectronic devices,module,Display the product and its related products,Technology development in the field of materials,technology transfer,Technical Consulting and Technical Services;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval),Sales of plastic products,Manufacturing of plastic products,Home Appliance Sales,Wholesale of computer software, hardware and auxiliary equipment(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA.

Hangzhou Hanku Medical Laboratory Co., Ltd., established on 2015-07-06, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development;Class I Medical Device Leasing;Class II Medical Device Leasing;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Medical Laboratory(clinical chemistry laboratory,clinical immunoassay,Clinical Cytomolecular Genetic Testing)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Symphogen is a biotechnology company located in Copenhagen, Denmark that develops protein drugs based on recombinant monoclonal antibody mixtures. These drugs are different from the polyclonal antibodies, as each antibody in the mixture is produced from one carefully selected clone. Their three main areas of therapeutic research are immunoglobulin replacement, cancer, and infectious diseases. The company was founded in 2000 and has patents on a drug discovery platform called Symplex and a drug manufacturing platform called Sympress. Currently, ten drugs are being developed with rozrolimupab (Sym001) being the lead product.

Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs. Their value chain extends from pre-clinical and clinical development to worldwide marketing and distribution. Biotest manufactures immunoglobulins, clotting factors and albumins which derive from human blood plasma. Biotest also develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus which are produced by recombinant technologies. Biotest currently employs more than 2,500 people worldwide. The most important raw material for their pharmaceuticals is human blood plasma, which they process into effective and highly purified drugs in one of their world leading fractionation facilities in Europe. These medications are used to treat life-threatening diseases such as blood coagulation disorders (haemophilia), severe infections and immune system disorders.

Terumo is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare.